Programme

Tue 27 April 2010
08:00 20:00		Registration

08:45 10:15		Symposium 18: Diabetes in pregnancy Room: Forum Hall Chairs: E. Anastasiou (Greece) & R. Lehmann (Switzerland)
08:45	S18.1	Progress towards new criteria for diagnosis and classification of glucose metabolism during pregnancy A. Kautzky-Willer (Austria)
09:15	S18.2	New treatment modalities in diabetic pregnancy C. Worda (Austria)
09:45	S18.3	Gestational diabetes: High risk for future diabetes and cardiovascular disease G. Schernthaner (Austria)

08:45 10:15		Symposium 19: Fetal microchimerism as an explanation of disease Room: Meeting Hall I Chairs: L. Fugazzola (Italy) & U. Feldt-Rasmussen (Denmark)
08:45	S19.1	Microchimerism: Introduction and animal models K. O'Donoghue (UK)
09:15	S19.2	Molecular microchimerism detection - its importance for non-invasive prenatal diagnosis and preeclampsia W. Holzgreve (Switzerland)
09:45	S19.3	The role of microchimerism in autoimmune diseases K. Badenhoop (Germany)

08:45 10:15		Young Active Research (YAR) Symposium: The way to human metabolic diseases' Room: Panorama Hall Chairs: S. Schmid (Germany) & D.M. Schulte (Germany)
08:45		Welcome & Introduction to YAR (DGE-ESE) S. M. Schmid (Germany)
08:50		Relationship between metabolic parameters and central dopaminergic activity in healthy men L. Brunerova (Czech Republic)
09:00		Novel syndromes of abnormal insulin sensitivity - lessons for common disease R. Semple (UK)
09:30		The GG genotype of the G-11391A ADIPOQ poylmorphism might be a risk factor for development of type 2 diabetes mellitus in women J. Polosak (Poland)
09:40		Adipose tissue development and human metabolic disease M. Laudes (Germany)
10:10		Closing and invitation for the YAR meeting in 2010 D. Schulte (Germany)

10:15 11:00		Plenary Lecture 5 Room: Main Auditorium Chairs: M. Haluzik (Czech Republic) & A. Sjoholm (Sweden)
10:15	PL5	Discovery and relevance of the Incretin System D. Drucker (Canada)

11:00 11:15		Coffee Break and Exhibition Room: Exhibition Hall

11:15 12:45		Symposium 20: The endocrine incidentaloma Room: Main Auditorium Chairs: J. Marek ( Czech Republic) & V. Popovic (Serbia)
11:15	S20.1	Thyroid incidentaloma. Endocrine incidentaloma P. Vitti (Italy)
11:45	S20.2	Pituitary incidentalomas M. Coculescu (Romania)
12:15	S20.3	Adrenal Incidentalomas S. Tsagarakis (Greece)

11:15 12:45		Symposium 21: The cardiometabolic interface Room: Forum Hall Chairs: V. Pirags (Latvia) & E. Fliers (The Netherlands)
11:15	S21.1	Endothelial dysfunction in type 2 diabetes T. Nystrom (Sweden)
11:45	S21.2	Role of PPAR signalling in diabetic dyslipidemia B. Staels (France)
12:15	S21.3	Mechanism and treatment of diabetic dyslipidemia M. Vrablik (Czech Republic)

11:15 12:45		Symposium 22: MicroRNAs in endocrinology Room: Meeting Hall I Chairs: S. Costagiola (Belgium) & J. Kruetzfeldt (Switzerland)
11:15	S22.1	MicroRNAs in biology H. Leffers (Denmark)
11:45	S22.2	MicroRNAs in thyroid cancer K. Jazdzewsji (Poland)
12:15	S22.3	The role of microRNAs in hormone signaling D. Picard (Switzerland)

11:15 12:45		Oral Communications 5: Reproduction & Thyroid Room: Panorama Hall Chairs: M. Simoni (Italy) & V. Zamrazil (Czech Republic)
11:15	OC5.1	Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model Presenter: Erica Gentilin
11:30	OC5.2	The influence of cure of subclinical hyperthyroidism on diastolic diameters of heart chambers and cardiac index Presenter: Grzegorz Kaminski
11:45	OC5.3	Socio-economic factors and mortality in Turner syndrome – a registry study Presenter: Kirstine Stochholm
12:00	OC5.4	One hormone, two functions - The chorionic gonadotropin in New World Monkeys Presenter: Christian Adams
12:15	OC5.5	Predictive factors of intermittent ovarian function in Patients with Premature Ovarian Failure Presenter: Maud Bidet
12:30	OC5.6	Universal screening detects twice more thyroid disorders in early pregnancy than targeted high-risk case finding Presenter: Jiri Horacek

13:00 14:30		Lunch & Exhibition Room: Exhibition Hall

13:00 15:30		Poster session: Talk to me!

13:00 14:00		Meet the Expert 1: Delayed puberty in boys Room: Forum Hall E. Malecka-Tendera (Poland)

13:00 14:00		Meet the Expert 2: Primary hyperaldosteronism Room: Meeting Hall I J. Widimsky (Czech Republic)

13:00 14:00		Meet the Expert 3: Modern approach to the adult patient with Turner Syndrome Room: Panorama Hall C. Gravholt (Denmark)

13:00 14:00		Meet the Expert 4: Disorders of sexual development (DSD) Room: Main Auditorium I. Hughes (UK)

14:30 15:30		Meet the Expert 5: How do you choose your treatment in inoperable pancreatic NET? Room: Forum Hall B. Kos-Kudla (Poland)

14:30 15:30		Meet the Expert 6: Management of Graves' ophthalmopathy Room: Meeting Hall I G. Krassas (Greece)

14:30 15:30		Meet the Expert 7: Cushing's Syndrome Room: Panorama Hall M. Boscaro (Italy)

14:30 15:30		Meet the Expert 8: Hyponatraemia: Diagnosis and novel treatments Room: Main Auditorium C. Thompson (Ireland)

15:30 17:00		Symposium 23: Obesity: clinical manifestations and therapeutic intervention Room: Main Auditorium Chairs: A. Pfeifer (Germany) & A. Lewinski (Poland)
15:30	S23.1	Obesity: clinical manifestations and therapeutic. Does the choice of diet make any difference? C. Mantzoros (USA)
16:00	S23.2	Lifestyle intervention and pharmacologic approaches to weight loss J. Tomlinson (UK)
16:30	S23.3	Hormonal changes after bariatric surgery M. Guldstrand (Sweden)

15:30 17:00		Symposium 24: Diagnosis and treatment of endocrine malignancies Room: Forum Hall Chairs: A. Tabarin (France) & G. Kaltsas (Greece)
15:30	S24.1	Malignant pheochromocytomas or paragangliomas P-F. Plouin (France)
16:00	S24.2	Diagnosis and treatment of adrenocortical carcinomas M. Fassnacht (Germany)
16:30	S24.3	Parathyroid carcinomas B. Szende (Hungary)

15:30 17:00		Symposium 25: Non-classical responses to hormones Room: Meeting Hall I Chairs: T. Scanlon (USA) & G. Brabant (UK)
15:30	S25.1	Rapid androgen action in epithelial and stromal cells. G. Castoria (Italy)
15:50	S25.2	Non-classical actions of oestrogens in pancreas A. Nadal (Spain)
16:10	S25.3	Protein kinase D as a modulator of aldosterone action in the kidney W. Thomas (Ireland)
16:30	S25.4	Extranuclear effects of thyroid hormones S. Incerpi (Italy)

15:30 17:00		Oral Communications 6: Bone Room: Panorama Hall Chairs: A. Giustina (Italy) & J. Bollerslev (Norway)
15:30	OC6.1	A proteomic approch to study parathyroid glands Presenter: Filomena Cetani
15:45	OC6.2	Association between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism Presenter: Laura Gianotti
16:00	OC6.3	Six novel mutations in 25-hydroxyvitamin D3 1alpha hydroxylase gene in patients with pseudovitamin D deficiency rickets. Presenter: Genevieve Abeguilel
16:15	OC6.4	Age-dependent features of bone mineral density changes in male rats with hyperthyroidism Presenter: Vladyslav Povoroznyuk
16:30	OC6.5	The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma. Presenter: Etienne Cavalier
16:45	OC6.6	Suppression of Circulating Fibroblast Growth Factor-23 by Cinacalcet in Patients with Primary Hyperparathyroidism Presenter: Yasuo Imanishi

17:00 17:15		Coffee Break and Exhibition Room: Exhibition Hall

17:15 17:30		ESE Young Investigator Awards & Poster Prizes Sponsored by Novartis Room: Main Auditorium

17:30 18:15		Plenary Lecture 6 Room: Main Auditorium Chairs: I. Hughes (UK) & TBC
17:30	PL6	Sex and SOX R. Lovell-Badge (UK)

18:30 20:00		Annual General Meeting of the European Society of Endocrinology (ESE) Room: Panorama Hall